| 1 | Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future | Coautor: Duenas-Gonzalez, A, Gonzalez-Fierro, A, Domínguez-Gómez, G, Chavez-Blanco, A | 2025 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | WoS-id: 001308214900001
Scopus-id: 2-s2.0-85203340061
| 0 | 0 |
| 2 | Concurrent Genomic Alterations on Clinical Outcomes in Patients With Alk-rearranged NSCLC | 2ᵒ autor y autor de correspondencia: Duenas-Gonzalez A., Bornstein-Quevedo L. | 2025 | JOURNAL OF THORACIC ONCOLOGY | WoS-id: 001423980200001
Scopus-id: 2-s2.0-85215605399
| 0 | 0 |
| 3 | Increased amounts of cell-free DNA released from a culture with a high content of cancer stem cells | Coautor: Dueñas-González A., Fernández-Domínguez I.J., Pérez-Cárdenas E., Taja-Chayeb L., et al. | 2025 | Frontiers In Cell And Developmental Biology | WoS-id: 001466662600001
Scopus-id: 2-s2.0-105002307126
| 0 | 0 |
| 4 | Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal | Coautor: Duenas-Gonzalez, A, Robles-Bañuelos, B, Romo-Perez, A, Dominguez-Gomez, G, et al. | 2024 | CLINICAL & TRANSLATIONAL ONCOLOGY | WoS-id: 001117866300001
Scopus-id: 2-s2.0-85178943982
| 2 | 3 |
| 5 | The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer | Coautor: Dueñas-González A., De La Cruz-Sigüenza D.A., Reyes-Grajeda J.P., Velasco-Velázquez M.A., et al. | 2024 | MOLECULAR BIOLOGY REPORTS | WoS-id: 001147955900008
Scopus-id: 2-s2.0-85182846959
| 0 | 0 |
| 6 | PaSTe. Blockade of the Lipid Phenotype of Prostate Cancer as Metabolic Therapy: A Theoretical Proposal | Coautor: Duenas-Gonzalez A., Romo-Pérez A., Dominguez-Gomez G., Chavez-Blanco A.D., et al. | 2024 | CURRENT MEDICINAL CHEMISTRY | WoS-id: 001237807500003
Scopus-id: 2-s2.0-85193241054
| 1 | 1 |
| 7 | Multitargeted polypharmacotherapy for cancer treatment. theoretical concepts and proposals | 1ᵉʳ autor: Duenas-Gonzalez A., Gonzalez-Fierro A., Bornstein-Quevedo L., Gutierrez-Delgado F., et al. | 2024 | EXPERT REVIEW OF ANTICANCER THERAPY | WoS-id: 001265746600001
Scopus-id: 2-s2.0-85197804654
| 3 | 3 |
| 8 | N-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression | Coautor: Dueñas González A., Prestegui Martel B., Chávez-Blanco A.D., Domínguez-Gómez G., et al. | 2024 | Molecules | WoS-id: 001287878900001
Scopus-id: 2-s2.0-85200723067
| 0 | 0 |
| 9 | Combinational therapies for the treatment of advanced cervical cancer | 1ᵉʳ autor y autor de correspondencia: Duenas-Gonzalez A. | 2023 | EXPERT OPINION ON PHARMACOTHERAPY | WoS-id: 000809812000001
Scopus-id: 2-s2.0-85131598761
| 11 | 10 |
| 10 | Does Therapeutic Repurposing in Cancer Meet the Expectations of Having Drugs at a Lower Price? | Coautor: Duenas-Gonzalez, Alfonso, Gonzalez-Fierro, Aurora, Romo-Perez, Adriana, Chavez-Blanco, Alma, et al. | 2023 | CLINICAL DRUG INVESTIGATION | WoS-id: 000945554200001
Scopus-id: 2-s2.0-85149459958
| 7 | 6 |
| 11 | Data presentation of results from randomized cancer clinical trials. The case for trials in advanced cervical cancer. A critical appraisal. | 1ᵉʳ autor: Duenas Gonzalez A., Coronel J., Cabrera-Galeana P., Candelaria M., et al. | 2023 | F1000 Research | Scopus-id: 2-s2.0-85152933255
| 0 | 0 |
| 12 | Hereditary diffuse gastric cancer (HDGC). An overview | Coautor: Dueñas-González A., Taja-Chayeb, L., Vidal-Millan, S., Trejo-Becerril, C., et al. | 2022 | CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | WoS-id: 000791839700001
Scopus-id: 2-s2.0-85120887486
| 15 | 17 |
| 13 | BAPST. A Combo of Common Use Drugs as Metabolic Therapy for Cancer: A Theoretical Proposal | Coautor: Duenas-Gonzalez, Alfonso, Romo-Perez, Adriana, Dominguez-Gomez, Guadalupe, Chavez-Blanco, Alma, et al. | 2022 | Current Molecular Pharmacology | WoS-id: 000832916200002
Scopus-id: 2-s2.0-85134632200
| 2 | 2 |
| 14 | Progress in Metabolic Studies of Gastric Cancer and Therapeutic Implications | Coautor: Duenas-Gonzalez, Alfonso, Romo-Perez, Adriana, Dominguez-Gomez, Guadalupe, Chavez-Blanco, Alma, et al. | 2022 | CURRENT CANCER DRUG TARGETS | WoS-id: 000854088000001
Scopus-id: 2-s2.0-85134869778
| 6 | 6 |
| 15 | The health system and access to treatment in patients with cervical cancer in Mexico | Coautor: Duenas-Gonzalez A., Arango-Bravo E.A., Cetina-Pérez L.D.C., Galicia-Carmona T., et al. | 2022 | Frontiers in Oncology | WoS-id: 000898096600001
Scopus-id: 2-s2.0-85144069360
| 5 | 5 |
| 16 | Modifications on the tetrahydroquinoline scaffold targeting a phenylalanine cluster on GPER as antiproliferative compounds against renal, liver and pancreatic cancer cells | Coautor: González A.D., Méndez-Luna D., Morelos-Garnica L.A., García-Vázquez J.B., et al. | 2021 | Pharmaceuticals | WoS-id: 000610692600001
Scopus-id: 2-s2.0-85099377851
| 8 | 11 |
| 17 | Rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in diffuse large B-cell lymphoma | 2ᵒ autor y autor de correspondencia: Duenas-Gonzalez, Alfonso, Candelaria, Myrna | 2021 | Therapeutic Advances in Hematology | WoS-id: 000617275600001
| 21 | 0 |
| 18 | Pharmacological inhibition of tumor anabolism and host catabolism as a cancer therapy | Coautor: Duenas-Gonzalez, Alfonso, Schcolnik-Cabrera, Alejandro, Chavez-Blanco, Alma, Dominguez-Gomez, Guadalupe, et al. | 2021 | SCIENTIFIC REPORTS | WoS-id: 000626140000050
Scopus-id: 2-s2.0-85101997542
| 9 | 11 |
| 19 | The role of extracellular DNA (exDNA) in cellular processes | Coautor: Duenas-Gonzalez, Alfonso, Fernandez-Dominguez, Ileana J., Manzo-Merino, Joaquin, Taja-Chayeb, Lucia, et al. | 2021 | CANCER BIOLOGY & THERAPY | WoS-id: 000641329500001
Scopus-id: 2-s2.0-85104795217
| 16 | 17 |
| 20 | Perspectives on Drug Repurposing | Coautor y autor de correspondencia: Duenas-Gonzalez, Alfonso, Schcolnik-Cabrera, Alejandro, Juarez-Lopez, Daniel | 2021 | CURRENT MEDICINAL CHEMISTRY | WoS-id: 000647580600002
Scopus-id: 2-s2.0-85105009632
| 26 | 30 |
| 21 | LATE-ONSET HEMATOLOGICAL TOXICITY (LOHT) IN PATIENTS WITH B-CELL LYMPHOMAS: A SURVEY IN 758 CASES | 2ᵒ autor: Duenas-Gonzalez, Alfonso, Palacios-Campos, Adriana, Gutierrez-Hernandez, Olga, Candelaria-Hernandez, Myrna | 2021 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000662712600003
| 0 | 0 |
| 22 | Mouse Model for Efficient Simultaneous Targeting of Glycolysis, Glutaminolysis, and De Novo Synthesis of Fatty Acids in Colon Cancer | 2ᵒ autor y autor de correspondencia: Dueñas-Gonzalez A., Schcolnik-Cabrera, Alejandro | 2021 | Methods in Molecular Biology | WoS-id: 000684295200006
Scopus-id: 2-s2.0-85090242714
| 1 | 1 |
| 23 | A COHORT STUDY OF THE PROGNOSTIC IMPACT OF EXON-16 EZH2 MUTATIONS IN A MEXICAN-MESTIZO POPULATION OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA | Coautor: Dueñas-González A., Oñate-Ocaña L.F., Ponce-Martinez, Mayra, Taja-Chayeb, Lucia, et al. | 2021 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000755116800004
Scopus-id: 2-s2.0-85121957733
| 2 | 3 |
| 24 | Barriers for Pharmaceutical Innovation With Focus in Cancer Drugs, the Case of Mexico | 1ᵉʳ autor: Duenas-Gonzalez, Alfonso, Gonzalez-Fierro, Aurora | 2020 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | WoS-id: 000522455300011
Scopus-id: 2-s2.0-85079688882
| 5 | 6 |
| 25 | In Vitro Employment of Recombinant Taenia solium Calreticulin as a Novel Strategy Against Breast and Ovarian Cancer Stem-like Cells | Coautor: Dueñas-González A., Schcolnik-Cabrera, Alejandro, Juarez, Mandy, Oldak, Bernardo, et al. | 2020 | Archives Of Medical Research | WoS-id: 000528269300010
Scopus-id: 2-s2.0-85079664233
| 10 | 9 |
| 26 | Antitumor effects of ivermectin at clinically feasible concentrations support its clinical development as a repositioned cancer drug | Coautor: Duenas-Gonzalez, Alfonso, Juarez, Mandy, Schcolnik-Cabrera, Alejandro, Dominguez-Gomez, Guadalupe, et al. | 2020 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | WoS-id: 000536424500001
Scopus-id: 2-s2.0-85085592809
| 27 | 29 |
| 27 | The combination of orlistat, lonidamine and 6-diazo-5-oxo-L-norleucine induces a quiescent energetic phenotype and limits substrate flexibility in colon cancer cells | Coautor: Duenas-Gonzalez, Alfonso, Schcolnik-Cabrera, Alejandro, Chavez-Blanco, Alma, Dominguez-Gomez, Guadalupe, et al. | 2020 | ONCOLOGY LETTERS | WoS-id: 000563938300105
Scopus-id: 2-s2.0-85090322275
| 11 | 11 |
| 28 | Targeting breast cancer cells with g4 pamam dendrimers and valproic acid derivative complexes | Coautor: Dueñas-González A., Muñoz A.M., Fragoso-Vazquez, Manuel J., Martel, Berenice P., et al. | 2020 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | WoS-id: 000582759900010
Scopus-id: 2-s2.0-85090650459
| 7 | 7 |
| 29 | Investigation of HER-2 status, treatment response and survival analysis in cervical cancer patients | Coautor: Duenas-Gonzalez, Alfonso, Taja-Chayeb, Lucia, Cetina, Lucely, Cruz-Velazquez, Judith, et al. | 2020 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000598901600030
Scopus-id: 2-s2.0-85098846283
| 1 | 1 |
| 30 | IMMUNOTHERAPY TREATMENT AGAINST CERVICAL CANCER | Coautor: Dueñas-González A., Jimenez-Lima, Roberto, Arango-Bravo, Eder, Galicia-Carmona, Tatiana, et al. | 2020 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000613899300006
Scopus-id: 2-s2.0-85093706014
| 3 | 4 |
| 31 | Emerging DNA methylation inhibitors for cancer therapy: challenges and prospects | 2ᵒ autor y autor de correspondencia: Dueñas-González A., Gonzalez-Fierro A. | 2019 | Expert Review Of Precision Medicine And Drug Development | WoS-id: 000457495900005
Scopus-id: 2-s2.0-85060994191
| 8 | 12 |
| 32 | Pharmacodynamics of current and emerging treatments for cervical cancer | 1ᵉʳ autor: Duenas-Gonzalez, Alfonso, Gonzalez-Fierro, Aurora | 2019 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | WoS-id: 000478048700006
Scopus-id: 2-s2.0-85070346300
| 23 | 20 |
| 33 | Growth inhibition and transcriptional effects of ribavirin in lymphoma | Coautor: Duenas-Gonzalez, Alfonso, Dominguez-Gomez, Guadalupe, Cortez-Pedroza, Dominique, Chavez-Blanco, Alma, et al. | 2019 | ONCOLOGY REPORTS | WoS-id: 000482277900032
Scopus-id: 2-s2.0-85069729765
| 8 | 9 |
| 34 | A combination of inhibitors of glycolysis, glutaminolysis and de novo fatty acid synthesis decrease the expression of chemokines in human colon cancer cells | Coautor: Dueñas-González A., Schcolnik-Cabrera, Alejandro, Dominguez-Gomez, Guadalupe, Chavez-Blanco, Alma, et al. | 2019 | ONCOLOGY LETTERS | WoS-id: 000505576300140
Scopus-id: 2-s2.0-85075803609
| 14 | 14 |
| 35 | Barriers for Pharmaceutical Innovation With Focus in Cancer Drugs, the Case of Mexico | 1ᵉʳ autor: Duenas-Gonzalez A., Gonzalez-Fierro A. | 2019 | THERAPEUTIC INNOVATION & REGULATORY SCIENCE | Scopus-id: 2-s2.0-85064052917
| 0 | 1 |
| 36 | Ivermectin as an inhibitor of cancer stem-like cells | Coautor: Dueñas-González A., Dominguez-Gomez G., Chavez-Blanco A., Medina-Franco J.L., et al. | 2018 | MOLECULAR MEDICINE REPORTS | WoS-id: 000423224300171
Scopus-id: 2-s2.0-85039735236
| 53 | 57 |
| 37 | The multitargeted drug ivermectin: from an antiparasitic agent to a repositioned cancer drug | Coautor y autor de correspondencia: Duenas-Gonzalez, Alfonso, Juarez, Mandy, Schcolnik-Cabrera, Alejandro | 2018 | AMERICAN JOURNAL OF CANCER RESEARCH | WoS-id: 000426434500009
| 157 | 0 |
| 38 | Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy | Coautor: Duenas-Gonzalez, Alfonso, Schcolnik-Cabrera, Alejandro, Chavez-Blanco, Alma, Dominguez-Gomez, Guadalupe, et al. | 2018 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | WoS-id: 000432689500005
Scopus-id: 2-s2.0-85047314473
| 98 | 105 |
| 39 | Cytotoxic Activity and Structure?Activity Relationship of Triazole-Containing Bis(Aryl Ether) Macrocycles | Coautor: Duenas-Gonzalez, Alfonso, Hernandez-Vazquez, Eduardo, Chavez-Riveros, Alejandra, Romo-Perez, Adriana, et al. | 2018 | Chemmedchem | WoS-id: 000435773200005
Scopus-id: 2-s2.0-85048859367
| 15 | 16 |
| 40 | Comparison of DNA demethylating and histone deacetylase inhibitors hydralazine-valproate versus vorinostat-decitabine incutaneous t-cell lymphoma in HUT78 cells | Coautor y autor de correspondencia: Duenas-Gonzalez, Alfonso, Schcolnik-Cabrera, Alejandro, Dominguez-Gomez, Guadalupe | 2018 | American Journal of Blood Research | WoS-id: 000439430000001
| 16 | 0 |
| 41 | Epidemiological data on the nutritional status of cancer patients receiving treatment with concomitant chemoradiotherapy, radiotherapy or sequential chemoradiotherapy to the abdominopelvic area | Coautor: Duenas-Gonzalez A., Serralde-Zuniga A., Castro-Eguiluz D., Aguilar-Ponce J.L., et al. | 2018 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000440876300003
Scopus-id: 2-s2.0-85052871628
| 7 | 7 |
| 42 | Advancing clinical research globally: Cervical cancer research network from Mexico | Coautor: Dueñas-González A., Ager B.J., Gallardo-Rincón D., de León D.C., et al. | 2018 | Gynecologic Oncology Reports | WoS-id: 000441980600025
Scopus-id: 2-s2.0-85048774957
| 9 | 8 |
| 43 | Metabolic tumor volume changes assessed by interval (18)fluorodeoxyglucose positron emission tomography-computed tomography for the prediction of complete response and survival in patients with diffuse large B-cell lymphoma | Coautor: Dueñas-Gonzalez A., Oñate-Ocaña L.F., Cortés V., Castillo-Llanos R., et al. | 2018 | ONCOLOGY LETTERS | WoS-id: 000444763100006
Scopus-id: 2-s2.0-85049470577
| 13 | 12 |
| 44 | Carboplatin and low-dose paclitaxel. An effective regimen in older and comorbid patients with advanced cervical cancer. A phase II study | Coautor: Duenas-Gonzalez, A., Coronel, J., Cantu, D., Rodriguez-Morales, M., et al. | 2018 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000452166200026
Scopus-id: 2-s2.0-85058840910
| 2 | 1 |
| 45 | Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells | Coautor: Duenas-Gonzalez, Alfonso, Perez-Cardenas, Enrique, Taja-Chayeb, Lucia, Trejo-Becerril, Catalina, et al. | 2018 | ONCOTARGETS AND THERAPY | WoS-id: 000452770700001
Scopus-id: 2-s2.0-85058679750
| 5 | 4 |
| 46 | Computational Study of the Binding Modes of Diverse DPN Analogues on Estrogen Receptors (ER) and the Biological Evaluation of a New Potential Antiestrogenic Ligand | Coautor: Duenas-Gonzalez, A., Martinez-Archundia M., García-Vázquez J.B., Colin-Astudillo B., et al. | 2018 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | WoS-id: 000456868000001
Scopus-id: 2-s2.0-85045289241
| 2 | 3 |
| 47 | Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells | Coautor: Dueñas-González A., Martínez-Muñoz A., Prestegui-Martel B., Méndez-Luna D., et al. | 2018 | ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | WoS-id: 000456868000013
Scopus-id: 2-s2.0-85061967699
| 9 | 11 |
| 48 | Ultrasound, histopathological, and genetic features of uveal melanoma in a Mexican-Mestizo population | Coautor: Dueñas-González A., Delgado S., Rodriguez Reyes A., Mora Rios L., et al. | 2018 | Archivos de la Sociedad Espanola de Oftalmologia | Scopus-id: 2-s2.0-85024110406
| 0 | 4 |
| 49 | Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer | Coautor: Duenas-Gonzalez, Alfonso, Cervantes-Madrid, Diana, Dominguez-Gomez, Guadalupe, Gonzalez-Fierro, Aurora, et al. | 2017 | ONCOLOGY LETTERS | WoS-id: 000396998600133
Scopus-id: 2-s2.0-85011903654
| 21 | 21 |
| 50 | Efficacy of hydralazine and valproate in cutaneous T-cell lymphoma, a phase II study | Coautor: Dueñas-González, A., Espinoza-Zamora, J.R., Labardini-Méndez, J., Sosa-Espinoza, A., et al. | 2017 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | WoS-id: 000399605800008
Scopus-id: 2-s2.0-85012904936
| 21 | 22 |
| 51 | Understanding tumor anabolism and patient catabolism in cancer-associated cachexia | Coautor: Duenas-Gonzalez, Alfonso, Schcolnik-Cabrera, Alejandro, Chavez-Blanco, Alma, Dominguez-Gomez, Guadalupe | 2017 | AMERICAN JOURNAL OF CANCER RESEARCH | WoS-id: 000402257100007
Scopus-id: 2-s2.0-85019919594
| 40 | 46 |
| 52 | Exploring disparities in incidence and mortality rates of breast and gynecologic cancers according to the Human Development Index in the Pan-American region | Coautor: Dueñas-González A., Martínez-Mesa J., Werutsky G., Stefan M., et al. | 2017 | Public Health | WoS-id: 000407538900015
Scopus-id: 2-s2.0-85019988234
| 10 | 7 |
| 53 | Encouraging results with the compassionate use of hydralazine/valproate (TRANSKRIP?) as epigenetic treatment for myelodysplastic syndrome (MDS) | Coautor: Duenas-Gonzalez, Alfonso, Candelaria, Myrna, Burgos, Sebastian, Ponce, Mayra, et al. | 2017 | ANNALS OF HEMATOLOGY | WoS-id: 000413247400005
Scopus-id: 2-s2.0-85027859318
| 17 | 17 |
| 54 | Evaluation of ivermectin as an antitumoural drug | Coautor y autor de correspondencia: Duenas, Alfonso, Juarez, Mandy, Chavez, Alma | 2017 | CLINICAL & EXPERIMENTAL METASTASIS | WoS-id: 000429931800048
| 0 | 0 |
| 55 | Global strategies for the treatment of early-stage and advanced cervical cancer | 1ᵉʳ autor: Duenas-Gonzalez, Alfonso, Campbell, Sergio | 2016 | CURRENT OPINION IN OBSTETRICS & GYNECOLOGY | WoS-id: 000369670300003
Scopus-id: 2-s2.0-84952987149
| 66 | 67 |
| 56 | Developmental DNA methyltransferase inhibitors in the treatment of gynecologic cancers | 1ᵉʳ autor: Duenas-Gonzalez, Alfonso, Medina-Franco, Jose L., Chavez-Blanco, Alma, Dominguez-Gomez, Guadalupe, et al. | 2016 | EXPERT OPINION ON PHARMACOTHERAPY | WoS-id: 000370293100004
Scopus-id: 2-s2.0-84957943145
| 12 | 11 |
| 57 | The safety of drug treatments for cervical cancer | 1ᵉʳ autor: Duenas-Gonzaleza, Alfonso, Cetina, Lucely, Coronel, Jaime, Gonzalez-Fierro, Aurora | 2016 | EXPERT OPINION ON DRUG SAFETY | WoS-id: 000370389900001
Scopus-id: 2-s2.0-84958183579
| 7 | 8 |
| 58 | G80A SINGLE NUCLEOTIDE POLYMORPHISM IN REDUCED FOLATE CARRIER-1 GENE IN A MEXICAN POPULATION AND ITS IMPACT ON SURVIVAL IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA | Coautor: Duenas-Gonzalez, Alfonso, Candelaria, Myrna, Ojeda, Juan, Gutierrez-Hernandez, Olga, et al. | 2016 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000379988100008
Scopus-id: 2-s2.0-85021859466
| 3 | 4 |
| 59 | Viral inhibitors of NKG2D ligands for tumor surveillance | Coautor: Duenas-Gonzalez, Alfonso, Chavez-Blanco, Alma, Chacon-Salinas, Rommel, Dominguez-Gomez, Guadalupe, et al. | 2016 | EXPERT OPINION ON THERAPEUTIC TARGETS | WoS-id: 000386601200009
Scopus-id: 2-s2.0-84991627437
| 4 | 4 |
| 60 | Antitumor Effects of Systemic DNAse I and Proteases in an In Vivo Model | Coautor: Duenas-Gonzalez, Alfonso, Trejo-Becerril, Catalina, Perez-Cardenas, Enrique, Gutierrez-Diaz, Blanca, et al. | 2016 | INTEGRATIVE CANCER THERAPIES | WoS-id: 000388763000004
Scopus-id: 2-s2.0-84995739656
| 21 | 20 |
| 61 | N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells | Coautor: Duenas-Gonzalez, Alfonso, Prestegui-Martel, Berenice, Antonio Bermudez-Lugo, Jorge, Chavez-Blanco, Alma, et al. | 2016 | JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | WoS-id: 000390581400017
Scopus-id: 2-s2.0-84980316080
| 36 | 38 |
| 62 | Hydralazine-valproate: A repositioned drug combination for the epigenetic therapy of cancer | 1ᵉʳ autor y autor de correspondencia: Duenas-Gonzalez, A. | 2016 | TOXICOLOGY LETTERS | WoS-id: 000396848100143
| 0 | 0 |
| 63 | Clinical presentation and management of uveal melanoma (Review) | 2ᵒ autor: Duenas-Gonzalez, Alfonso, Rodriguez, Abelardo, Delgado-Pelayo, Sarai | 2016 | Molecular and Clinical Oncology | WoS-id: 000453169800002
| 14 | 0 |
| 64 | Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin | Coautor: DuenasGonzalez, A, Domínguez-Gómez G., Díaz-Chávez J., Chávez-Blanco A., et al. | 2015 | ONCOLOGY REPORTS | WoS-id: 000348338500028
Scopus-id: 2-s2.0-84919444238
| 22 | 21 |
| 65 | Ribavirin as a tri-targeted antitumor repositioned drug | Coautor: DuenasGonzalez, A, De La Cruz-Hernandez E., Medina-Franco J.L., Trujillo J., et al. | 2015 | ONCOLOGY REPORTS | WoS-id: 000353180900036
Scopus-id: 2-s2.0-84927127592
| 38 | 42 |
| 66 | Therapy-related myelodysplastic syndrome | 2ᵒ autor y autor de correspondencia: DuenasGonzalez, A, Candelaria M. | 2015 | EXPERT OPINION ON DRUG SAFETY | WoS-id: 000353209600005
Scopus-id: 2-s2.0-84928319854
| 9 | 13 |
| 67 | A pilot study of nimotuzumab plus single agent chemotherapy as second- or third-line treatment or more in patients with recurrent, persistent or metastatic cervical cancer | Coautor: DuenasGonzalez, A, Cetina L., Crombet T., Jiménez-Lima R., et al. | 2015 | CANCER BIOLOGY & THERAPY | WoS-id: 000354981300007
Scopus-id: 2-s2.0-84943752318
| 23 | 25 |
| 68 | Discovery and development of DNA methyltransferase inhibitors using in silico approaches This paper is dedicated to the memory of Dr Eugene Athanas Bratoeff Titeff honoring his many contributions to drug discovery. | Coautor: DuenasGonzalez, A, Medina-Franco J.L., Méndez-Lucio O., Yoo J. | 2015 | DRUG DISCOVERY TODAY | WoS-id: 000355714600009
Scopus-id: 2-s2.0-84929160714
| 44 | 49 |
| 69 | Emerging drugs for the treatment of cervical cancer | Coautor: DuenasGonzalez, A, Serrano-Olvera A., Cetina L., Coronel J. | 2015 | EXPERT OPINION ON EMERGING DRUGS | WoS-id: 000356118400002
Scopus-id: 2-s2.0-84930026306
| 29 | 27 |
| 70 | Antitumor effects of a drug combination targeting glycolysis, glutaminolysis and de novo synthesis of fatty acids | 2ᵒ autor y autor de correspondencia: DuenasGonzalez, A, CervantesMadrid, D | 2015 | ONCOLOGY REPORTS | WoS-id: 000359173100052
Scopus-id: 2-s2.0-84937207425
| 22 | 25 |
| 71 | Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy | Coautor y autor de correspondencia: DuenasGonzalez, A, Cervantes-Madrid D., Romero Y. | 2015 | BIOMED RESEARCH INTERNATIONAL | WoS-id: 000361698200001
Scopus-id: 2-s2.0-84942292107
| 85 | 98 |
| 72 | Nicotinamide sensitizes human breast cancer cells to the cytotoxic effects of radiation and cisplatin | Coautor: DuenasGonzalez, A, DominguezGomez, G, ChavezBlanco, A, DiazChavez, J, et al. | 2015 | INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | WoS-id: 000361863000195
| 0 | 0 |
| 73 | New pharmacotherapy options for cervical cancer | 1ᵉʳ autor: Duenas-Gonzalez, A, Cetina, L, Coronel, J, Cano, C, et al. | 2014 | EXPERT OPINION ON PHARMACOTHERAPY | WoS-id: 000328118800006
Scopus-id: 2-s2.0-84890756255
| 6 | 5 |
| 74 | The impact of DNA methylation technologies on drug toxicology | 1ᵉʳ autor: Duenas-Gonzalez, A, Alatorre, B, Gonzalez-Fierro, A | 2014 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | WoS-id: 000334606100002
Scopus-id: 2-s2.0-84898408896
| 4 | 8 |
| 75 | In Vivo Rat Model to Study Horizontal Tumor Progression | Coautor y autor de correspondencia: Dueñas-González A., Trejo-Becerril C., Pérez-Cárdenas E. | 2014 | Methods in Molecular Biology | WoS-id: 000338510500013
Scopus-id: 2-s2.0-84922032651
| 2 | 2 |
| 76 | Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure | Coautor: Duenas-Gonzalez, A, Garcés-Eisele S.J., Cedillo-Carvallo B., Reyes-Núñez V., et al. | 2014 | Journal Of Clinical Pharmacy And Therapeutics | WoS-id: 000339428100007
Scopus-id: 2-s2.0-84904197971
| 13 | 13 |
| 77 | Radiosensitization of cervical cancer cells with epigenetic drugs hydralazine and valproate | Coautor: Duenas-Gonzalez, A, Mani E., Medina L.A., Isaac-Olivé K. | 2014 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000341554600008
Scopus-id: 2-s2.0-84898950227
| 23 | 22 |
| 78 | Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer | 1ᵉʳ autor: Duenas-Gonzalez, A, Coronel J., Cetina L., González-Fierro A., et al. | 2014 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | WoS-id: 000342202600010
Scopus-id: 2-s2.0-84907167939
| 48 | 52 |
| 79 | Follow-up consultations for cervical cancer patients in a Mexican cancer center. Comparison with NCCN guidelines | Coautor: Duenas-Gonzalez, A, Serrano-Olvera, A, Cetina, L, Coronel, J | 2014 | ASIAN PACIFIC JOURNAL OF CANCER PREVENTION | WoS-id: 000351055100038
Scopus-id: 2-s2.0-84911191782
| 1 | 2 |
| 80 | New molecular targets against cervical cancer | 1ᵉʳ autor: Duenas-Gonzalez A., Serrano-Olvera A., Cetina L., Coronel J. | 2014 | INTERNATIONAL JOURNAL OF WOMENS HEALTH | Scopus-id: 2-s2.0-84928891453
| 0 | 51 |
| 81 | Relación entre niveles de CA-125 y características clínicas e histopato lógicas en el cáncer epitelial de ovario | Coautor: Dueñas-González A., Dolores-Velázquez R., Bustamante-Montes L.P., Romero-Fierro J.R., et al. | 2014 | GACETA MEXICANA DE ONCOLOGIA | Scopus-id: 2-s2.0-84946752983
| 0 | 1 |
| 82 | Planning cancer control in Latin America and the Caribbean | Coautor: Duenas-Gonzalez, A, Goss P.E., Lee B.L., Badovinac-Crnjevic T., et al. | 2013 | LANCET ONCOLOGY | WoS-id: 000318679700008
Scopus-id: 2-s2.0-84876852012
| 346 | 381 |
| 83 | A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for | Coautor: Duenas-Gonzalez A., Kast R.E., Boockvar J.A., Brüning A., et al. | 2013 | Oncotarget | WoS-id: 000318783800005
Scopus-id: 2-s2.0-84879165730
| 140 | 153 |
| 84 | Brachytherapy versus radical hysterectomy after external beam chemoradiation with gemcitabine plus cisplatin: A randomized, phase III study in IB2-IIB cervical cancer patients | Coautor: Duenas-Gonzalez, A, Cetina L., González-Enciso A., Cantú D., et al. | 2013 | ANNALS OF ONCOLOGY | WoS-id: 000322339300016
Scopus-id: 2-s2.0-84881240300
| 60 | 64 |
| 85 | A randomized comparison of cisplatin and oral vinorelbine as radiosensitizers in aged or comorbid locally advanced cervical cancer patients | Coautor: Duenas-Gonzalez, A, Coronel, JA, Cetina, LD, Cantu, D, et al. | 2013 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000330373500018
Scopus-id: 2-s2.0-84880424003
| 13 | 16 |
| 86 | An identical, complex TP53 mutation arising independently in two unrelated families with diverse cancer profiles: the complexity of interpreting cancer risk in carriers | Coautor: Duenas-Gonzalez, A, Pinto E.M., Ribeiro R.C., Li J., et al. | 2012 | ONCOGENESIS | WoS-id: 000209218600001
Scopus-id: 2-s2.0-84868608474
| 3 | 3 |
| 87 | Dna methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells | Coautor: Duenas-Gonzalez A., Candelaria M., de la Cruz-Hernandez E., Taja-Chayeb L., et al. | 2012 | PLOS ONE | WoS-id: 000302381500002
Scopus-id: 2-s2.0-84858044285
| 40 | 42 |
| 88 | Epigenetic Therapy With Hydralazine and Magnesium Valproate Reverses Imatinib Resistance in Patients With Chronic Myeloid Leukemia | Coautor: Duenas-Gonzalez, A, Cervera E., Candelaria M., López-Navarro O., et al. | 2012 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | WoS-id: 000304495800009
Scopus-id: 2-s2.0-84861087737
| 26 | 27 |
| 89 | Arylamine N-acetyltransferase 2 genotypes in a Mexican population | Coautor: Duenas-Gonzalez, A, Taja-Chayeb L., Agúndez J.A., Miguez-Muñoz C., et al. | 2012 | GENETICS AND MOLECULAR RESEARCH | WoS-id: 000305519600029
Scopus-id: 2-s2.0-84930474806
| 9 | 13 |
| 90 | Efficacy in high burden locally advanced cervical cancer with concurrent gemcitabine and cisplatin chernoradiotherapy plus adjuvant gemcitabine and cisplatin: Prognostic and pre | 1ᵉʳ autor: Duenas-Gonzalez, A, Orlando, M, Zhou, Y, Quinlivan, M, et al. | 2012 | GYNECOLOGIC ONCOLOGY | WoS-id: 000307322000004
Scopus-id: 2-s2.0-84864403468
| 40 | 45 |
| 91 | Late recurrence of cervical cancer: a report of 16 cases | Coautor: Duenas-Gonzalez, A, Cetina, L, Garcia-Arias, A, Aguila, C, et al. | 2012 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000309738600009
Scopus-id: 2-s2.0-84868602986
| 3 | 3 |
| 92 | Cancer Progression Mediated by Horizontal Gene Transfer in an In Vivo Model | Coautor: Duenas-Gonzalez, A, Trejo-Becerril C., Pérez-Cárdenas E., Taja-Chayeb L., et al. | 2012 | PLOS ONE | WoS-id: 000313051500055
Scopus-id: 2-s2.0-84871676294
| 95 | 111 |
| 93 | Randomized, double blind, phase II trial: Epigenetic therapy (valproic acid and hydralazine) plus chemotherapy versus placebo plus neoadjuvant chemotherapy in operable and local | 2ᵒ autor: Duenas-Gonzalez, A, Arce, C, Mohar, A, Medina, FUL, et al. | 2011 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000208880303363
| 0 | 0 |
| 94 | Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial | Coautor: Duenas-Gonzalez, A, Candelaria M., Herrera A., Labardini J., et al. | 2011 | ANNALS OF HEMATOLOGY | WoS-id: 000288212800002
Scopus-id: 2-s2.0-79955701085
| 61 | 64 |
| 95 | F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma | Coautor: Duenas-Gonzalez, A, Cetina L., Serrano A., Cantú-de-León D., et al. | 2011 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000294274900003
Scopus-id: 2-s2.0-80052128417
| 15 | 15 |
| 96 | Pharmacokinetics of hydralazine, an antihypertensive and DNA-demethylating agent, using controlled-release formulations designed for use in dosing schedules based on the acetyla | Coautor: Duenas-Gonzalez, A, Gonzalez-Fierro, A, Vasquez-Bahena, D, Taja-Chayeb, L, et al. | 2011 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | WoS-id: 000294534500005
Scopus-id: 2-s2.0-80052216583
| 18 | 22 |
| 97 | Upregulation of NKG2D ligands and enhanced natural killer cell cytotoxicity by hydralazine and valproate | Coautor: Duenas-Gonzalez, A, Chávez-Blanco A., De La Cruz-Hernández E., Domínguez G.I., et al. | 2011 | INTERNATIONAL JOURNAL OF ONCOLOGY | WoS-id: 000296315400015
Scopus-id: 2-s2.0-80054797849
| 45 | 45 |
| 98 | Acetylator status and N-acetyltransferase 2 gene polymorphisms; Phenotype-genotype correlation with the sulfamethazine test | Coautor: Duenas-Gonzalez, A, Taja-Chayeb L., González-Fierro A., Miguez-Muñoz C., et al. | 2011 | PHARMACOGENETICS AND GENOMICS | WoS-id: 000296799900014
Scopus-id: 2-s2.0-81055157800
| 12 | 14 |
| 99 | Pharmacokinetic evaluation of gemcitabine hydrochloride for the treatment of cervical cancer | 1ᵉʳ autor: Duenas-Gonzalez, A, Coronel, J, Cetina, L | 2011 | EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | WoS-id: 000297176400011
Scopus-id: 2-s2.0-81855183739
| 5 | 6 |
| 100 | Polymorphism in exon 4 of TP53 gene associated to HPV 16 and 18 in Mexican women with cervical cancer | Coautor: Duenas-Gonzalez, A, Pina-Sanchez, P, Hernández-Hernández D.M., Taja-Chayeb L., et al. | 2011 | MEDICAL ONCOLOGY | WoS-id: 000297256400086
Scopus-id: 2-s2.0-84655175075
| 13 | 13 |
| 101 | A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary resul | Coautor: Duenas-Gonzalez, A, Coronel J., Cetina L., Pacheco I., et al. | 2011 | MEDICAL ONCOLOGY | WoS-id: 000301047200081
Scopus-id: 2-s2.0-84655175030
| 107 | 113 |
| 102 | The place of topotecan and other drugs in the management of advanced/relapsed cervix cancer | Coautor y autor de correspondencia: Dueñas-González A., Coronel J., Cetina L. | 2011 | European journal of Clinical and Medical Oncology | Scopus-id: 2-s2.0-79960076159
| 0 | 0 |
| 103 | Epigenetic changes in nucleoside transporter hENT1 and dCK, as mechanism for gemcitabine-aquired resistance in cervical cancer cell lines. | Coautor: Duenas-Gonzalez, A, Candelaria, M, de la Cruz-Hernandez, E, Gonzalez-Fierro, A, et al. | 2010 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000208852000484
| 0 | 0 |
| 104 | Pharmacotherapy Options for Locally Advanced and Advanced Cervical Cancer | 1ᵉʳ autor: Duenas-González A., Cetina L., Coronel J., Martínez-Baños D. | 2010 | Drugs | WoS-id: 000276278400003
Scopus-id: 2-s2.0-77949287219
| 17 | 18 |
| 105 | Epigenetic therapy and cisplatin chemoradiation in FIGO Stage IIIB cervical cancer | Coautor: Duenas-Gonzalez, A, Candelaria M., Cetina L., Pérez-Cárdenas E., et al. | 2010 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000280394400007
Scopus-id: 2-s2.0-77956123071
| 35 | 34 |
| 106 | Pharmacogenetics and pharmacoepigenetics of gemcitabine | Coautor: Duenas-Gonzalez, A, Candelaria M., De La Cruz-Hernández E., Pérez-Cárdenas E., et al. | 2010 | MEDICAL ONCOLOGY | WoS-id: 000284547800019
Scopus-id: 2-s2.0-79951771016
| 24 | 27 |
| 107 | Primer consenso Mexicano de cáncer de endometrio: Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM" | Coautor: Dueñas-González A., Ruvalcaba-Limón E., Cantú-de-León D., León-Rodríguez E., et al. | 2010 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000288234900013
Scopus-id: 2-s2.0-79953115171
| 8 | 5 |
| 108 | [The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México]. [Primer consenso Mexicano de cancer de endometrio.] | Coautor: Dueñas-González A., Ruvalcaba-Limón E., Cantú-de-León D., León-Rodríguez E., et al. | 2010 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | WoS-id: 000288234900013
Scopus-id: 2-s2.0-79955714746
| 8 | 4 |
| 109 | Response to hydralazine-valproate in a patient with mycosis fungoides | 1ᵉʳ autor: Dueñas-Gonzalez A., Vega M.T., Martinez-Baños D., Garciáa-Hidalgo L., et al. | 2010 | Case Reports In Medicine | Scopus-id: 2-s2.0-84971335537
| 0 | 9 |
| 110 | E6 variants of human papillomavirus 18 differentially modulate the protein kinase B/phosphatidylinositol 3-kinase (akt/PI3K) signaling pathway | Coautor: Duenas-Gonzalez, A, Contreras-Paredes, A, de la Cruz-Hernandez, E, Martinez-Ramirez, I, et al. | 2009 | Virology | WoS-id: 000262447300010
Scopus-id: 2-s2.0-57149116328
| 79 | 81 |
| 111 | Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients | Coautor: Duenas-Gonzalez, A, Cetina L., Garcia-Arias A., Candelaria M., et al. | 2009 | WORLD JOURNAL OF SURGICAL ONCOLOGY | WoS-id: 000263846000001
Scopus-id: 2-s2.0-62149140984
| 17 | 22 |
| 112 | Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer | Coautor: Duenas-Gonzalez, A, Coronel J., Cetina L., Candelaria M., et al. | 2009 | MEDICAL ONCOLOGY | WoS-id: 000266166900016
Scopus-id: 2-s2.0-67651031402
| 15 | 20 |
| 113 | Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1 | 2ᵒ autor: Duenas-Gonzalez, A, Singh N., Lyko F., Medina-Franco J.L. | 2009 | Chemmedchem | WoS-id: 000266385000012
Scopus-id: 2-s2.0-67651089970
| 97 | 103 |
| 114 | Mutational analysis of BRCA1 and BRCA2 genes in Mexican breast cancer patients | Coautor: Duenas-Gonzalez, A, Vidal-Millán S., Taja-Chayeb L., Gutiérrez-Hernández O., et al. | 2009 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000270030600014
Scopus-id: 2-s2.0-70350054850
| 16 | 16 |
| 115 | Lack in efficacy for imatinib mesylate as second-line treatment of recurrent or metastatic cervical cancer expressing platelet-derived growth factor receptor a | Coautor: Duenas-Gonzalez, A, Candelaria M., Arias-Bonfill D., Chávez-Blanco A., et al. | 2009 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000272898400033
Scopus-id: 2-s2.0-77649193788
| 25 | 33 |
| 116 | Identification of a novel germ-line mutation in the TP53 gene in a Mexican family with Li-Fraumeni syndrome | Coautor: Duenas-Gonzalez, A, Taja-Chayeb L., Vidal-Millán S., Gutiérrez-Hernández O., et al. | 2009 | WORLD JOURNAL OF SURGICAL ONCOLOGY | WoS-id: 000273817500001
Scopus-id: 2-s2.0-74549177509
| 4 | 4 |
| 117 | Thiopurine S-methyltransferase Gene (TMPT) polymorphisms in a Mexican population of healthy individuals and leukemic patients | Coautor: Duenas-Gonzalez, A, Taja-Chayeb, L, Vidal-Millan, S, Gutierrez, O, et al. | 2008 | MEDICAL ONCOLOGY | WoS-id: 000252280800008
Scopus-id: 2-s2.0-42949155888
| 20 | 24 |
| 118 | The epigenetic origin of aneuploidy | Coautor: Duenas-Gonzalez, A, Herrera, LA, Prada, D, Andonegui, MA | 2008 | CURRENT GENOMICS | WoS-id: 000254654800006
Scopus-id: 2-s2.0-41549161985
| 55 | 57 |
| 119 | Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors | 1ᵉʳ autor: Duenas-Gonzalez A., Candelaria M., Perez-Plascencia C., Perez-Cardenas E., et al. | 2008 | CANCER TREAT REV | WoS-id: 000256326000002
Scopus-id: 2-s2.0-42649109021
| 295 | 311 |
| 120 | Concurrent chemoradiation with carboplatin for elderly, diabetic and hypertensive patients with locally advanced cervical cancer | Coautor: Duenas-Gonzalez, A, Cetina, L, Garcia-Arias, A, Uribe, MD, et al. | 2008 | EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY | WoS-id: 000260301200010
Scopus-id: 2-s2.0-56749122221
| 28 | 33 |
| 121 | The prince and the pauper. A tale of anticancer targeted agents | 1ᵉʳ autor: Duenas-Gonzalez, A, García-López P., Herrera L.A., Medina-Franco J.L., et al. | 2008 | MOLECULAR CANCER | WoS-id: 000262378700001
Scopus-id: 2-s2.0-58249116704
| 73 | 78 |
| 122 | Activación de la vía de Wnt/beta catenina en el proceso de carcinogenesis cervical | 2ᵒ autor: Dueñas-Gonzalez A., Pérez-Plasencia C., Bustos-Martínez J. | 2008 | Archivos de Medicina | Scopus-id: 2-s2.0-54949123382
| 0 | 49 |
| 123 | The prognostic significance of leukocytosis in cervical cancer | Coautor: Dueñas-González A., Garcia-Arias A., Cetina L., Candelaria M., et al. | 2007 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000244885300022
Scopus-id: 2-s2.0-33947246972
| 24 | 30 |
| 124 | Treatment of the adenocarcinoma of the esophagogastric junction at a single institution in Mexico | Coautor: Dueñas-González A., Oñate-Ocaña L.F., Milán-Revollo G., Aiello-Crocifoglio V., et al. | 2007 | ANNALS OF SURGICAL ONCOLOGY | WoS-id: 000245362300026
Scopus-id: 2-s2.0-34047226343
| 8 | 9 |
| 125 | The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study | Coautor: Dueñas-González A., De La Cruz-Hernández E., Pérez-Cárdenas E., Contreras-Paredes A., et al. | 2007 | VIROLOGY JOURNAL | WoS-id: 000247517200002
Scopus-id: 2-s2.0-33847772150
| 55 | 62 |
| 126 | A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors | Coautor: Dueñas-González A., Candelaria M., Gallardo-Rincón D., Arce C., et al. | 2007 | ANNALS OF ONCOLOGY | WoS-id: 000250437200016
Scopus-id: 2-s2.0-34548395116
| 208 | 232 |
| 127 | Primary retroperitoneal mucinous cystadenocarcinoma: Report of two cases | Coautor: Dueñas-González A., Cantú De León D., Pérez-Montiel D., Chanona-Vilchis J., et al. | 2007 | WORLD JOURNAL OF SURGICAL ONCOLOGY | Scopus-id: 2-s2.0-33846864688
| 0 | 35 |
| 128 | Tamoxifen-associated vasculitis in a breast cancer patient | Coautor: Duenas-Gonzalez A., Candelaria M., Hurtado-Monroy R., Vargas-Viveros P., et al. | 2007 | WORLD JOURNAL OF SURGICAL ONCOLOGY | Scopus-id: 2-s2.0-33846971221
| 0 | 9 |
| 129 | Primary retroperitoneal mucinous cystadenocarcinoma: report of two cases. | Coautor: Dueñas-González A., De León D.C., Pérez-Montiel D., Chanona-Vilchis J., et al. | 2007 | WORLD JOURNAL OF SURGICAL ONCOLOGY | Scopus-id: 2-s2.0-69149084640
| 0 | 15 |
| 130 | Radiosensitizers in cervical cancer. Cisplatin and beyond | Coautor: Dueñas-Gonzalez A., Candelaria M., Garcia-Arias A., Cetina L. | 2006 | RADIAT ONCOL | WoS-id: 000204479500015
Scopus-id: 2-s2.0-33845416730
| 75 | 84 |
| 131 | A proof-of-principle study of epigenetics therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer | Coautor: Dueñas-González A., Arce C., Pérez C., González-Fierro A., et al. | 2006 | PLOS ONE | WoS-id: 000207443600097
Scopus-id: 2-s2.0-33847786883
| 121 | 131 |
| 132 | Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines | Coautor: Duenas-Gonzalez A., Chavez-Blanco A., Perez-Plasencia C., Perez-Cardenas E., et al. | 2006 | CANCER CELL INTERNATIONAL | WoS-id: 000208405000002
Scopus-id: 2-s2.0-33645071947
| 108 | 124 |
| 133 | Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer | 2ᵒ autor: Dueñas-González A., Serrano-Olvera A., Gallardo-Rincón D., Candelaria M., et al. | 2006 | CANCER TREAT REV | WoS-id: 000237684500003
Scopus-id: 2-s2.0-33645907542
| 117 | 123 |
| 134 | Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population | Coautor: Dueñas-González A., Lizano M., De la Cruz-Hernández E., Carrillo-García A., et al. | 2006 | GYNECOLOGIC ONCOLOGY | WoS-id: 000239347600018
Scopus-id: 2-s2.0-33746018323
| 53 | 55 |
| 135 | Can the state of cancer chemotherapy resistance be reverted by epigenetic therapy? | 2ᵒ autor y autor de correspondencia: Duenas-Gonzalez A., Perez-Plasencia C. | 2006 | MOLECULAR CANCER | WoS-id: 000239969500001
Scopus-id: 2-s2.0-33747341830
| 26 | 32 |
| 136 | Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine | Coautor: Duenas-González A., Segura-Pacheco B., Perez-Cardenas E., Taja-Chayeb L., et al. | 2006 | JOURNAL OF TRANSLATIONAL MEDICINE | WoS-id: 000240479200001
Scopus-id: 2-s2.0-33748967231
| 72 | 89 |
| 137 | Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid | 2ᵒ autor: Duenas-González A., Mora-García M. de L., Hernández-Montes J., De la Cruz-Hernández E., et al. | 2006 | JOURNAL OF TRANSLATIONAL MEDICINE | WoS-id: 000243718900002
Scopus-id: 2-s2.0-33846862931
| 67 | 69 |
| 138 | A novel one pot, solvent-free Mannich synthesis of methylpiperidinyl phenols, methylphenylmorpholinyl phenols and methylthiophenylmorpholinyl phenols using infrared light irradiation | Coautor: Dueñas-González A., Velázquez A.Ma., Torres L.A., Díaz G., et al. | 2006 | Arkivoc | Scopus-id: 2-s2.0-31544445509
| 0 | 18 |
| 139 | Prognostic significance of pathological response after neoadjuvant chemotherapy of chemoradiation for locally advanced cervical carcinoma | Coautor: Dueñas-Gonzalez A., Candelaria M., Chanona-Vilchis J., Cetina L., et al. | 2006 | International Seminars in Surgical Oncology | Scopus-id: 2-s2.0-33644640421
| 0 | 32 |
| 140 | Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results | Coautor: Dueñas-González A., Cetina L., Rivera L., Hinojosa J., et al. | 2006 | BMC Womens Health | Scopus-id: 2-s2.0-33644663022
| 0 | 39 |
| 141 | Pathologic response and toxicity assessment of chemoradiotherapy with cisplatin versus cisplatin plus gemcitabine in cervical cancer: A randomized Phase II study | 1ᵉʳ autor: Dueñas-González A., Cetina-Perez L., Lopez-Graniel C., Gonzalez-Enciso A., et al. | 2005 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | WoS-id: 000227052900024
Scopus-id: 2-s2.0-13844298686
| 55 | 64 |
| 142 | Determination of 5-methyl-cytosine and cytosine in tumor DNA of cancer patients | Coautor: Dueñas-Gonzalez A., Sandoval Guerrero K., Revilla Vázquez A., Segura-Pacheco B. | 2005 | Electrophoresis | WoS-id: 000228170600005
Scopus-id: 2-s2.0-17144374845
| 20 | 20 |
| 143 | A clinical and biological overview of gastrointestinal stromal tumors | Coautor y autor de correspondencia: Duenas-Gonzalez A., Candelaria M., De La Garza J. | 2005 | MEDICAL ONCOLOGY | WoS-id: 000229104300001
Scopus-id: 2-s2.0-18444402504
| 13 | 14 |
| 144 | A phase I study of hydralazine to demythylate and reactivate the expression of tumor suppressor genes | Coautor: Duenas-González A., Zambrano P., Segura-Pacheco B., Perez-Cardenas E., et al. | 2005 | Bmc Cancer | WoS-id: 000229218400001
Scopus-id: 2-s2.0-26844499872
| 124 | 146 |
| 145 | Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer | Coautor: Duenas A., Vazquez-Ortiz G., Pina-Sanchez P., Vazquez K., et al. | 2005 | Bmc Cancer | WoS-id: 000230476400001
Scopus-id: 2-s2.0-25444511458
| 78 | 73 |
| 146 | Anemia in cervical cancer patients: Implications for iron supplementation therapy | Coautor y autor de correspondencia: Dueñas-González A., Candelaria M., Cetina L. | 2005 | MEDICAL ONCOLOGY | WoS-id: 000230692900008
Scopus-id: 2-s2.0-22344449466
| 17 | 20 |
| 147 | Serum nucleosomes during neoadjuvant chemotherapy in patients with cervical cancer. Predictive and prognostic significance | Coautor: Duenas-Gonzalez A., Trejo-Becerril C., Oñate-Ocaña L.F., Taja-Chayeb L., et al. | 2005 | Bmc Cancer | WoS-id: 000230966000001
Scopus-id: 2-s2.0-26844548732
| 12 | 12 |
| 148 | Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences | Coautor: Dueñas-González A., De la Cruz-Hernández E., García-Carrancá A., Mohar-Betancourt A., et al. | 2005 | JOURNAL OF GENERAL VIROLOGY | WoS-id: 000231482100008
Scopus-id: 2-s2.0-23844477702
| 35 | 40 |
| 149 | Genetic determinants of cancer drug efficacy and toxicity: Practical considerations and perspectives | Coautor: Dueñas-Gonzalez A., Candelaria M., Taja-Chayeb L., Arce-Salinas C., et al. | 2005 | ANTI-CANCER DRUGS | WoS-id: 000232563300004
Scopus-id: 2-s2.0-26244444364
| 21 | 24 |
| 150 | Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer | Coautor: Duenas-Gonzalez A., Lopez-Graniel C., Dolores R., Cetina L., et al. | 2005 | Bmc Cancer | WoS-id: 000232692700001
Scopus-id: 2-s2.0-26844481072
| 9 | 13 |
| 151 | Response to gefitinib in bronchioloalveolar carcinoma in the absence of EGFR mutation | Coautor: Duenas-Gonzalez A., Taja-Chayeb L., Candelaria M., Brom R., et al. | 2005 | LUNG CANCER | WoS-id: 000232973600013
Scopus-id: 2-s2.0-26444607483
| 7 | 6 |
| 152 | Erratum: Overexpression of cathepsin f, matrix metalloproteinases 11 and 12 in cervical cancer (BMC Cancer) | Coautor: Dueñas A., Vàzquez-Ortiz G., Piña-Sanchez P., Vázquez K., et al. | 2005 | Bmc Cancer | WoS-id: 000234719800001
Scopus-id: 2-s2.0-30544431625
| 3 | 17 |
| 153 | Computational studies of 1-hydrazinophthalazine (hydralazine) as an antineoplasic agent. Docking studies on methyltransferase | Coautor: Dueñas-González A., Angeles E., Vázquez-Valadéz V.H., Vázquez-Valadéz O., et al. | 2005 | LETTERS IN DRUG DESIGN & DISCOVERY | WoS-id: 000235167600005
Scopus-id: 2-s2.0-20644466016
| 25 | 25 |
| 154 | Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study | Coautor: Duenas-Gonzalez A., Chavez-Blanco A., Segura-Pacheco B., Perez-Cardenas E., et al. | 2005 | MOLECULAR CANCER | WoS-id: 000239965000001
Scopus-id: 2-s2.0-26844505068
| 116 | 126 |
| 155 | Epigenetics of cervical cancer. An overview and therapeutic perspectives | 1ᵉʳ autor: Dueñas-González A., Lizano M., Candelaria M., Cetina L., et al. | 2005 | MOLECULAR CANCER | WoS-id: 000239966700001
Scopus-id: 2-s2.0-27744492604
| 176 | 195 |
| 156 | Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: Case report and review of the literature | Coautor: Dueñnas-Gonzalez A., Arce C., Cortes-Padilla D., Huntsman D.G., et al. | 2005 | WORLD JOURNAL OF SURGICAL ONCOLOGY | Scopus-id: 2-s2.0-27444440803
| 0 | 53 |
| 157 | Phase II trial of gemcitabine concurrent with radiation for locally advanced squamous cell carcinoma of the head and neck | Coautor: Dueñas-González A., Aguilar-Ponce J.-L., Granados-García M., Villavicencio V., et al. | 2004 | ANNALS OF ONCOLOGY | WoS-id: 000188973500022
Scopus-id: 2-s2.0-10744224541
| 34 | 31 |
| 158 | HER2 expression in cervical cancer as a potential therapeutic target | Coautor: Dueñas-Gonzalez A., Chavez-Blanco A., Perez-Sanchez V., Gonzalez-Fierro A., et al. | 2004 | Bmc Cancer | WoS-id: 000224043200001
Scopus-id: 2-s2.0-13144302944
| 59 | 65 |
| 159 | Chemoradiation with gemcitabine for cervical cancer in patients with renal failure | Coautor: Duenas-Gonzalez A., Cetina L., Rivera L., Candelaria M., et al. | 2004 | ANTI-CANCER DRUGS | WoS-id: 000224111400004
Scopus-id: 2-s2.0-4644318305
| 14 | 22 |
| 160 | Ether à go-go potassium channels as human cervical cancer markers | Coautor: Dueñas-González A., Farias L.M.B., Ocaña D.B., Díaz L., et al. | 2004 | CANCER RESEARCH | WoS-id: 000224292400025
Scopus-id: 2-s2.0-4944252457
| 122 | 133 |
| 161 | Ocular metastases from breast carcinoma | Coautor: Dueñas-González A., Mejía-Novelo A., Alvarado-Miranda A., Morales-Vázquez F., et al. | 2004 | MEDICAL ONCOLOGY | WoS-id: 000224684900002
Scopus-id: 2-s2.0-7944233091
| 12 | 12 |
| 162 | Circulating nucleosomes and response to chemotherapy: An in vitro, in vivo and clinical study on cervical cancer patients | Coautor: Dueñas-González A., Trejo-Becerril C., Pérez-Cárdenas E., Treviño-Cuevas H., et al. | 2003 | INTERNATIONAL JOURNAL OF CANCER | WoS-id: 000182214900001
Scopus-id: 2-s2.0-0345701255
| 56 | 59 |
| 163 | Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy | Coautor: Dueñas-Gonzalez A., Segura-Pacheco B., Trejo-Becerril C., Perez-Cardenas E., et al. | 2003 | CLINICAL CANCER RESEARCH | WoS-id: 000182813200004
Scopus-id: 2-s2.0-10744225448
| 188 | 210 |
| 164 | Long-term results of paclitaxel in FIGO stage III ovarian carcinoma | Coautor: Dueñas-Gonzalez A., Gallardo-Rincón D., Pérez-Landeros L., Oñate-Ocaña L.F., et al. | 2003 | ANTI-CANCER DRUGS | WoS-id: 000183465000004
Scopus-id: 2-s2.0-0037841294
| 2 | 2 |
| 165 | Induction chemotherapy with gemcitabine and oxaliplatin for locally advanced cervical carcinoma | 1ᵉʳ autor: Dueñas-González A., López-Graniel C., González A., Gomez E., et al. | 2003 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | WoS-id: 000183708600005
Scopus-id: 2-s2.0-0037320561
| 20 | 24 |
| 166 | A Phase I study of carboplatin concurrent with radiation in FIGO stage IIIB cervix uteri carcinoma | 1ᵉʳ autor: Duenas-Gonzalez A., Cetina L., Sánchez B., Gomez E., et al. | 2003 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | WoS-id: 000184256000019
Scopus-id: 2-s2.0-0037489691
| 27 | 32 |
| 167 | Modern management of locally advanced cervical carcinoma | 1ᵉʳ autor: Dueñas-Gonzalez A., Cetina L., Mariscal I., de la Garza J. | 2003 | CANCER TREAT REV | WoS-id: 000185698500004
Scopus-id: 2-s2.0-18344402418
| 76 | 81 |
| 168 | Correlation of tumor growth index with early treatment response in cervical carcinoma | Coautor: Dueñas-González A., Trejo-Becerril C., Rivera L., Chanona J., et al. | 2002 | J EXP CLIN CANC RES | WoS-id: 000175017700009
Scopus-id: 2-s2.0-0036222925
| 3 | 3 |
| 169 | Type III radical hysterectomy induction chemotherapy for patients with locally advanced cervical carcinoma (multiple letters) | Coautor: Dueñas-González A., Lopez-Graniel C., Chanona G., Mohar A., et al. | 2002 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000175252400018
Scopus-id: 2-s2.0-0036244962
| 0 | 0 |
| 170 | Neoadjuvant chemotherapy followed by surgery in locally advanced cervical carcinoma [4] (multiple letters) | 1ᵉʳ autor: Duenas-Gonzalez A., Lopez-Graniel C.M., Mota A., Mohar A., et al. | 2002 | JOURNAL OF CLINICAL ONCOLOGY | WoS-id: 000176289200025
Scopus-id: 2-s2.0-0037096748
| 3 | 10 |
| 171 | A pilot study of perilymphatic leukocyte cytokine mixture (IRX-2) as neoadjuvant treatment for early stage cervical carcinoma: Preliminary report | 1ᵉʳ autor: Dueñas-Gonzalez A., Verastegui E., Lopez-Graniel C., Gonzalez A., et al. | 2002 | INTERNATIONAL IMMUNOPHARMACOLOGY | WoS-id: 000177265200016
Scopus-id: 2-s2.0-0036310145
| 7 | 8 |
| 172 | Concomitant chemoradiation versus neoadjuvant chemotherapy in locally advanced cervical carcinoma: Results from two consecutive phase II studies | 1ᵉʳ autor: Duenas-Gonzalez A., Lopez-Graniel C., Gonzalez-Enciso A., Mohar A., et al. | 2002 | ANNALS OF ONCOLOGY | WoS-id: 000177641000011
Scopus-id: 2-s2.0-0036668662
| 34 | 46 |
| 173 | Neuroendocrine marker expression in cervical carcinomas of non-small cell type | Coautor: Dueñas-Gonzalez A., Chavez-Blanco A., Taja-Chayeb L., Cetina L., et al. | 2002 | INT J GYNECOL PATHOL | WoS-id: 000178179500006
Scopus-id: 2-s2.0-0036783702
| 17 | 21 |
| 174 | The advantages of concurrent chemoradiation after neoadjuvant chemotherapy for locally advanced cervical carcinoma | 1ᵉʳ autor: Dueñas-González A., Rivera L., Mota A., López-Graniel C., et al. | 2002 | Archives Of Medical Research | Scopus-id: 2-s2.0-0036118770
| 4 | 7 |
| 175 | Cervical cancer. The case of Mexico | 1ᵉʳ autor y autor de correspondencia: Dueñas-González A. | 2002 | CLINICAL & TRANSLATIONAL ONCOLOGY | Scopus-id: 2-s2.0-84873479111
| 0 | 0 |
| 176 | Weekly cisplatin/low-dose gemcitabine combination for advanced and recurrent cervical carcinoma | 1ᵉʳ autor: Dueñas-Gonzalez A., Hinojosa-García L.M., López-Graniel C., Meléndez-Zagla J., et al. | 2001 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | WoS-id: 000168186300020
Scopus-id: 2-s2.0-0035052827
| 13 | 14 |
| 177 | A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma | 1ᵉʳ autor: Dueñas-Gonzalez A., Lopez-Graniel C., Gonzalez A., Reyes M., et al. | 2001 | ANNALS OF ONCOLOGY | WoS-id: 000168326800028
Scopus-id: 2-s2.0-17344390754
| 49 | 58 |
| 178 | Type III radical hysterectomy after induction chemotherapy for patients with locally advanced cervical carcinoma | Coautor: Dueñas-Gonzalez A., Lopez-Graniel C., Reyes M., Chanona G., et al. | 2001 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000169693200008
Scopus-id: 2-s2.0-0034944924
| 19 | 22 |
| 179 | Membrane proteins in neoplasic and normal uterine cervix | Coautor: Dueñas-González A., Trejo-Becerril C., Pérez-Cárdenas E., Taja-Chayeb L., et al. | 2001 | J EXP CLIN CANC RES | WoS-id: 000169911600011
Scopus-id: 2-s2.0-0034934471
| 0 | 0 |
| 180 | Cisplatin and vinorelbine in epithelial ovarian cancer in first line treatment. Pilot study [Cisplatino y vinorelbina en pacientes con cáncer de ovario epitelial como tratamiento de primera línea. Estudio piloto] | 2ᵒ autor: Dueñas-González A., Ruiz G.C., Graniel C.M.L., Herrera L.O., et al. | 2001 | CLINICAL & TRANSLATIONAL ONCOLOGY | Scopus-id: 2-s2.0-84873660054
| 0 | 0 |
| 181 | Immunohistochemical expression of p53 in breast carcinoma is associated with the intron 1 BglII polymorphism of the p53 gene | Coautor: Dueñas-González A., Trejo-Becerril C., Sarmiento R.G., Abad M.M., et al. | 2000 | MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS | WoS-id: 000089963400009
Scopus-id: 2-s2.0-0034683563
| 2 | 2 |
| 182 | Bioavailability of etoposide after oral administration of the solution marketed for intravenous use: Therapeutic and pharmacoeconomic perspectives | Coautor: Dueñas-González A., Ponce J.L.A., Flores-Picazo Y., Pérez-Urizar J., et al. | 1999 | Archives Of Medical Research | WoS-id: 000081379100009
Scopus-id: 2-s2.0-0344299261
| 7 | 9 |
| 183 | Adjuvant high-dose chemotherapy supported by peripheral blood stem cell transplantation for high-risk cervical carcinoma | 1ᵉʳ autor: Duenas-Gonzalez A., Lara-Medina F.U., Solorza-Luna G., Mota-Garcia A., et al. | 1999 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | WoS-id: 000082105100011
Scopus-id: 2-s2.0-0032771418
| 0 | 1 |
| 184 | Neoadjuvant chemotherapy-interferon for epidermoid penile cancer. A case report | 1ᵉʳ autor: Duenas-Gonzalez A., Jimenez-Rios M.A., Ponce J.L.A., Lizano M., et al. | 1999 | Revista Del Instituto Nacional De Cancerología | Scopus-id: 2-s2.0-0032737832
| 0 | 0 |
| 185 | The estrogen gen receptor in breast cancer. Friend or enemy? [El gen del receptor de estrogenos en el cancer de mama. Amigo o enemigo?] | 1ᵉʳ autor y autor de correspondencia: Duenas Gonzalez A. | 1999 | Revista Del Instituto Nacional De Cancerología | Scopus-id: 2-s2.0-0032998986
| 0 | 0 |
| 186 | Expression of inducible nitric oxide synthase in breast cancer correlates with metastatic disease | 1ᵉʳ autor: Dueñas-Gonzalez A., Isales C.M., Del Mar Abad-Hernandez M., Gonzalez-Sarmiento R., et al. | 1997 | MODERN PATHOLOGY | WoS-id: A1997XK17700001
Scopus-id: 2-s2.0-0342894681
| 77 | 80 |
| 187 | Analysis of bcl-2 in sporadic breast carcinoma | 1ᵉʳ autor: Dueñas-González A., Abad-Hernández M.D.M., Cruz-Hernández J.-J., González-Sarmiento R. | 1997 | CANCER | WoS-id: A1997YG86800009
Scopus-id: 2-s2.0-1842413726
| 22 | 28 |
| 188 | Analysis of nm23-H1 expression in breast cancer. Correlation with p53 expression and clinicopathologic findings | 1ᵉʳ autor: Dueñas-González A., Abad-Hernández M.M., García-Mata J., Paz-Bouza J.I., et al. | 1996 | CANCER LETTERS | WoS-id: A1996UB00300001
Scopus-id: 2-s2.0-0007831448
| 21 | 17 |
| 189 | Use of GM-CSF as prophylaxis of ganciclovir-induced-severe bone marrow suppression [Prevención de mielotoxicidad en un caso de trasplante medular con factor estimulante de colonias granulocito-macrófago asociado a ganciclovir] | 2ᵒ autor: Dueñas González A., Reynoso Gómez E., Miranda López E., Sobrevilla Calvo P., et al. | 1996 | REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION | Scopus-id: 2-s2.0-0029886483
| 0 | 1 |
| 190 | Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: A randomized double-blind study | 1ᵉʳ autor: Dueñas-Gonzalez A., Sobrevilla-Calvo P., Frias-Mendivil M., Gallardo-Rincon D., et al. | 1996 | BONE MARROW TRANSPL | WoS-id: A1996UK31400023
Scopus-id: 2-s2.0-0030013953
| 38 | 48 |
| 191 | Higher sensitivity of the PCR-SSCP technique than the immunohistochemical technique for the detection of mutation in the exons 5 and 6 of the p53 gene in breast cancer [Mayor sensibilidad de la técnica de RCP-SSCP frente a la inmunohistoqu | 1ᵉʳ autor: Dueñas González A., Cruz Hernández J.J., Abad Hernández M.M., Ramos M., et al. | 1996 | MEDICINA CLINICA | Scopus-id: 2-s2.0-0030592081
| 0 | 2 |
| 192 | Adult acute lymphoblastic leukemia. Experience at the Instituto Nacional de Cancerologia, 1983-1987 [LEUCEMIA LINFOBLASTICA AGUDA DEL ADULTO. EXPERIENCIA DEL INSTITUTO NACIONAL DE CANCEROLOGIA DE 1983 A 1987] | Coautor: Duenas Gonzalez A., Reynoso Gomez E.E., Andrade D., De Jesus Sobrevilla Calvo P. | 1994 | Revista Del Instituto Nacional De Cancerología | Scopus-id: 2-s2.0-0027968142
| 0 | 0 |
| 193 | Apoptosis and cancer [APOPTOSIS Y CANCER] | 1ᵉʳ autor: Duenas Gonzalez A., Cruz Hernandez J.J., Gonzalez Sarmiento R. | 1994 | Revista Del Instituto Nacional De Cancerología | Scopus-id: 2-s2.0-0028597948
| 0 | 0 |
| 194 | Drug repurposing for cancer therapy, easier said than done | 2ᵒ autor y autor de correspondencia: Dueñas-González A., Gonzalez-Fierro A. | | SEMINARS IN CANCER BIOLOGY | WoS-id: 000616365300012
Scopus-id: 2-s2.0-85077160531
| 46 | 51 |
ID's SCOPUS 
ORCID's 